Medicine Diagnostic Market PowerPoint PPT Presentations

Read here the latest updates on the Cell Surface Markers Market published by CMI team.

The report provides value and growth of the global personal therapeutics market from 2017-2021. Also historic figures back to 2014 are given to illustrate growth. As the personal targeted therapeutics market is part of the overall personalized medicine market, the companion diagnostics market is also included in the report

This report focuses on the global Precision Medicine Diagnostics status, future forecast, growth opportunity, key market and key players.

This report describes the current technologies that are propelling the personalized medicine and companion diagnostic market. See Full Report: http://goo.gl/daXMJ8

Analysis of major geographic regions, including North America, Europe, Japan and Latin America. Discussion of trends in X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS and other technologies. Read The Complete Report On : http://www.bigmarketresearch.com/2015-global-diagnostic-imaging-market

Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportunities, Competitor Analysis & Forecasts to 2017

This report describes the current technologies that are propelling the personalized medicine and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomics revolution are discussed.

TechNavios analysts forecast the Global Personalized Medicine Diagnostics market to grow at a CAGR of 4.43 percent over the period 2012-2016

The global diagnostic Imaging market is segmented on the basis of technology, type, application and geography. According to technology, the market is segmented into Radiography Equipment, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Equipment, Fluoroscopy, and Mammography.

In the report, the market has been segmented on the basis of technology, product type, application, and end-users. On the basis of technology, the molecular diagnostics market is expected to grow at the highest CAGR from 2012 to 2017.

New Market Research Reports Title Critical Care Diagnostics Market" Has Been Added to Adroit Market Research into reports database.

The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lions share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope.

The report on In-vitro Diagnostics Instruments Market by product (immunochemistry, clinical microbiology, POCT, tissue diagnostics, molecular diagnostics, hematology, hemostasis, SMBG), end user(hospitals and diagnostic laboratories, research institutes) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global In-vitro Diagnostics Instruments Market is projected to grow at a CAGR of 9.3% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

Rise in prominence of personalized medicine, surge in cases of adverse drug reactions, and advancements in technologies for diagnostic techniques drive the growth in the global companion diagnostics market.

Global Geriatric Medicine Market size was estimated to be US$ 677.5 million in 2019 and is growing at a CAGR of 6.7% during 2021 – 2028. Hastily aging population across the globe primarily in emerging and developed economies made geriatric a concern among the public health. Geriatric medicine is referred as a branch of medicine associated to preventive, healing and clinical illness for the age group belonging above 65 years. Maturing body continually tends to vulnerability and geriatric which inclines for neurological, cardiovascular and respiratory sickness. Geriatric drugs are vital part for therapeutic science giving improved diagnostic for the aging population which propels the market to thrive. Alarming chronic diseases amid geriatrics such as cancers, diabetes and arthritis attributes for market progress.

Veterinary medicine is termed as any product used to treat various medical conditions in animals. For instance, veterinary medicine include drugs such as anti-infective drugs and parasiticides, which are administered orally in animals

Bharatbook.com announces Markets Research Reports. These reports is a global provider of consulting and information services that combine data refining, expert analysis and application-based client focused reports. These allow users to achieve return on investment in a limited time frame. The gaming industry is moving ahead rapidly with constant innovations. Multiplayer, role playing games and different genres have increased the number of people using these games.

The Global Precision Medicine Market is expected to register 12.48% CAGR and is anticipated to reach USD 126.14 Billion by 2025

Read here the market research report on the “Patent Medicine Market" published by CMI Team

Read here the market research report on the “Cancer Diagnostics Market" published by CMI Team

The Asia-Pacific nuclear medicine market size was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.

The adoption of transplant diagnostics (including both pre- and post-transplant screening) is expected to witness a significant rise with increasing prevalence of chronic diseases that can lead to organ failure.

Artificial intelligence (AI) in medicine is used to analyze complex medical data by approximating human cognition with the help of algorithms and software. The development of novel pharmaceuticals and biologicals through clinical trials can take more than a decade and cost billions of dollars during that tenure period

According to Renub Research report, tittled “Autoimmune Disease Diagnostic Market, Size. Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Autoimmune Disease Diagnostics Market will be USD 8.02 Billion by 2027. Autoimmune disorders are a species of more than 80 chronic diseases, out of which multiple sclerosis, Systemic Lupus Erythematosus (SLE), rheumatoid arthritis, and type I diabetes are the most common autoimmune diseases. An autoimmune disease transfers to a condition wherein the immune system destroys and attacks healthy cells, organs of the body, and tissues. In the longer run, it can further lead to abnormal growth of an organ and changes in organ function.

Read here the latest updates on the Molecular Diagnostics Market published by CMI team

The Asia-Pacific nuclear medicine market size was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.

This report, from Stratview Research, studies the global clinical diagnostics market - companion diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025.

The Global Molecular Diagnostics Market is expected to attain a market size of $11.2 billion by 2022, growing at a CAGR of 8.6% during the forecast period. Full Report: https://kbvresearch.com/global-molecular-diagnostics-market/

The ELISA tests market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 7.23% in the forecast period of 2021 to 2028. The growing incidence of infectious diseases will help in escalating the growth of the ELISA tests market. https://www.databridgemarketresearch.com/reports/global-elisa-tests-market

The Global Molecular Diagnostics Market is expected to attain a market size of $11.2 billion by 2022, growing at a CAGR of 8.6% during the forecast period. Full Report: https://kbvresearch.com/global-molecular-diagnostics-market/

The major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc...@@ https://bit.ly/2XCz1CE

The Nuclear Medicine Equipment Market size is projected to reach $2.6 billion by 2026, with a CAGR of 4.6% during the forecast period 2021-2026. Nuclear medicine involves the use of radioactive substances called radiotracers used in the diagnosis and treatment of illnesses such as cardiovascular diseases, neurological diseases, cancers, and so on. The radiotracers are injected, inhaled, or swallowed by the patient and then emit gamma radiation that can be detected by nuclear imaging devices.

The Global Molecular Diagnostics Market is expected to attain a market size of $11.2 billion by 2022, growing at a CAGR of 8.6% during the forecast period. Full report: http://kbvresearch.com/global-molecular-diagnostics-market/

The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period. A companion diagnostics test is done to understand which patient can gain benefits from a specific drug or decide upon the kind of dosage that should be prescribed. All of this, on the basis of a patients clinical diagnosis, which offers required evidence for the successful and harmless utilization of an equivalent biological or drug product to treat the medical issue. These can also be referred to as medical instruments that help doctors in electing which dosage or treatment is sufficient for patients and suits to their necessity. Full Report: https://www.kbvresearch.com/companion-diagnostics-market/

Read here the latest updates on the Biomarker research services market analysis published by the CMI team.

China In Vitro Diagnostics Market will be USD 22.3 Billion by 2026. Forecast by Segment (Clinical Chemistry, Immunoassay, Molecular Testing, Microbiology, Hematology, SMBG, Point of Care Testing, Coagulation), Company Analysis.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Nuclear Medicine for these regions, from 2012 to 2023 (forecast)

The global Network Performance Monitoring and Diagnostics (NPMD) market size is expected to reach USD 7.93 Billion in 2028 and register a steady revenue CAGR of 15.8% over the forecast period, according to latest analysis by Emergen Research.

Non-Oncology Precision Medicine market is segmented by Ecosystem, and by Application. Players, stakeholders, and other participants in the global Non-Oncology Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource.

Global DNA Sequencing Market size is projected to be valued $26 Billion by 2025; with a CAGR of 18.7% from 2017 to 2025. DNA sequencing is the blueprint which contains genetic information, used in understanding its evolution or function. DNA sequencing helps in the understanding of genetic biology and the technique is now widely being used in the field of medical research. Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used globally.

In-Vitro Diagnostics Market Research Report, By Product & Services, By Applications, By End User - Forecast 2027

Global DNA Sequencing Market size is projected to be valued $26 Billion by 2025; with a CAGR of 18.7% from 2017 to 2025. DNA sequencing is the blueprint which contains genetic information, used in understanding its evolution or function. DNA sequencing helps in the understanding of genetic biology and the technique is now widely being used in the field of medical research. Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used globally.

Global DNA Sequencing Market size is projected to be valued $26 Billion by 2025; with a CAGR of 18.7% from 2017 to 2025. DNA sequencing is the blueprint which contains genetic information, used in understanding its evolution or function. DNA sequencing helps in the understanding of genetic biology and the technique is now widely being used in the field of medical research. Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used globally.

The global precision medicine market is expected to grow from $62.75 billion in 2020 to $72.58 billion in 2021 at a compound annual growth rate (CAGR) of 15.7%.

Dental Sleep Medicine Market Information: by treatment & diagnostics (positive airway pressure (pap) therapy, oral and nasal devices, airway systems, other devices, drugs, surgery, polysomnography and polygraphy, oximetry and actigraph), by end users - global forecast till 2027

IVD market growth is driven by factors such as increase in incidences of chronic and infectious diseases across all age cohorts, genetic diseases, aging population, rising acceptance of personalized medicine, rise in healthcare awareness in patients and high unmet medical needs in diagnosing diseases.

According to Renub Research analysis Global Molecular Diagnostics Market is likely to surpass US$ 22.5 Billion by the end of year 2025. By Application (2019 - 2025). Access full Research: https://www.renub.com/global-molecular-diagnostics-market-and-future-forecast-2010-2014-334-p.php

This report studies the global market size of Radiopharmaceuticals in Nuclear Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiopharmaceuticals in Nuclear Medicine in these regions.

Looking forward, the companion diagnostics market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/companion-diagnostics-market

Veterinary Medicine Market business research report assesses the current as well as the upcoming performance of the market, and also brand-new trends in the market. It provides a product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report are displayed in a statistical format to offer a better understanding of the market dynamics.

Tissue diagnostic procedures are majorly used for cancer diagnosis. Some of the major tissue diagnostic tests are immunochemistry (IHC), haematoxylin and eosin (H&E), and in situ hybridization (ISH)

Nuclear Medicine/ Radiopharmaceuticals Market is expected to garner $8,207.5 million by 2022. The market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear medicine.

Looking forward, the oncology molecular diagnostics market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/oncology-molecular-diagnostics-market

Radiopharmaceuticals is a medical specialty that uses specific radiotracers, and have emerged as an efficient imaging technology in the field of nuclear medicine. The non-invasive nature of radiopharmaceuticals has quickened the diagnosis of various diseases such as cardiovascular diseases, neurological disorders, and cancers.

Get more details @ http://bit.ly/2l3rNQ4 Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics

The global expansion of the medicine industry will expand the canvas of the global precision market. Larger investments, better infrastructure, simplified approval process of drugs along with companion diagnostics will impact the structure of the entire climate of the global precision medicine market.